Search
for
Sort by
Research 691–720 of 1000+
- Polycystic Ovary Syndrome: Diagnosis and Treatment
- Endocrine Influences on Hair Growth
- Emerging nonmetabolic functions of skin fat
- Polycystic ovary syndrome and the risk of obstructive sleep apnea: a meta-analysis and review of the literature
- Fadrozole and finasteride exposures modulate sex steroid- and thyroid hormone-related gene expression in Silurana (Xenopus) tropicalis early larval development
- The Role of Oral Contraceptives in the Treatment of Hyperandrogenic Disorders
- A case series of 20 women with hidradenitis suppurativa treated with spironolactone
- Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism
- Polycystic Ovary Syndrome (PCOS) and Other Androgen Excess–Related Conditions: Can Changes in Dietary Intake Make a Difference?
- Emotion Dysregulation of Women with Premenstrual Syndrome
- Chrousos syndrome: from molecular pathogenesis to therapeutic management
- Hormonal treatment of acne vulgaris: an update
- Testosterone therapy for sexual dysfunction in postmenopausal women
- Combined hormonal contraception and venous thromboembolism
- Roles of tumor suppressors in regulating tumor-associated inflammation
- Mitoxantrone
- Metabolomic biomarkers in women with polycystic ovary syndrome: a pilot study
- Evidence-based approach to cutaneous hyperandrogenism in women
- Mood disorders and quality of life in polycystic ovary syndrome
- Androgens and Antiandrogens
- Polycystic ovary syndrome in Salvador, Brazil: a prevalence study in primary healthcare
- Non polycystic ovary syndrome–related endocrine disorders associated with hirsutism
- Side effects of common acne treatments
- Approach to the Management of Patients With Hidradenitis Suppurativa: A Consensus Document
- Vitamin D receptor polymorphisms and the polycystic ovary syndrome: A systematic review
- PLASMA C19 STEROID SULPHATE LEVELS AND INDICES OF ANDROGEN BIOAVAILABILITY IN FEMALE PATTERN ANDROGENIC ALOPECIA
- CAG Repeat Testing of Androgen Receptor Polymorphism: Is This Necessary for the Best Clinical Management of Hypogonadism?
- Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome
- The VEGF +405 G>C 5' untranslated region polymorphism and risk of PCOS: a study in the South Indian Women
- Androgenic alopecia and insulin resistance: are they really related?